Founded in 2015 in Moscow City, Russian Federation, Primer Capital specializes in crowdfunding, early stage ventures, private equity, and seed rounds. They have made 10 investments, with their most recent investment being in MatriSys Bioscience in October 2018. Their portfolio includes companies such as Acticor Biotech, Gemopharm LLC, and Bendit. Primer Capital works closely with venture capital funds, business angels, and government agencies to support the development of the biopharmaceutical industry. They provide portfolio companies with expertise and resources to establish effective relationships with key partners and ensure a successful growth trajectory.